Attached files
| file | filename |
|---|---|
| EX-4.1 - EX-4.1 - Axogen, Inc. | ex-4d1.htm |
| EX-10.51 - EX-10.51 - Axogen, Inc. | ex-10d51.htm |
| EX-21.1 - EX-21.1 - Axogen, Inc. | ex-21d1.htm |
| EX-23.1 - EX-23.1 - Axogen, Inc. | ex-23d1.htm |
| EX-31.1 - EX-31.1 - Axogen, Inc. | ex-31d1.htm |
| EX-31.2 - EX-31.2 - Axogen, Inc. | ex-31d2.htm |
| EX-32.1 - EX-32.1 - Axogen, Inc. | ex-32d1.htm |
| 10-K - 10-K - Axogen, Inc. | axgn-20191231x10k0cc357.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements Nos. 333-224713, 333-207829 and 333-220770 on Form S-3 and Registration Statements Nos. 333-227105, 333-222019, 333-218290, 333-211660, 333-201238, 333-177980, 333-230418, 333-233416 and 333-173539 on Form S-8 of our report dated February 24, 2020, relating to the financial statements and financial statement schedule of Axogen, Inc., and the effectiveness of Axogen, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K of Axogen, Inc. for the year ended December 31, 2019.
/s/ DELOITTE & TOUCHE LLP
Miami, Florida
February 24, 2020